Exploring the relationship of platelet aggregation function with efficacy and safety outcomes following the administration of prasugrel and clopidogrel in patients with thrombotic stroke: a post hoc analysis of PRASTRO pooled studies
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-025-03093-3
Abstract: The P2Y12 receptor inhibitor prasugrel was approved for thrombotic stroke in Japan following the phase 3 clinical trials PRASTRO-I, -II, and -III. However, correlations between elevated platelet reaction unit (PRU) and ischemic event risk remain… read more here.
Keywords: prasugrel clopidogrel; analysis prastro; thrombotic stroke; pru ... See more keywords